Researchers designing clinical trials often specify usual care received by participants as the control condition expecting that all participants receive usual care regardless of group assignment. The assumption is that the groups in the study are affected similarly. We describe the assessment of usual care within the 16 studies in Multisite Adherence Collaboration in HIV (MACH 14), a multisite collaboration on adherence to antiretroviral therapy. Only five of the studies in MACH 14 assessed usual care. Assessment protocols varied as did the timing and frequency of assessments. All usual care assessments addressed patient education focused on HIV, HIV medications,
and medication adherence. Our findings support earlier work that calls for systematic assessments of usual care within the study design, inclusion of descriptions of usual care in reports of the study, and the influence of usual care on the experimental condition in clinical trials.
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Investigators conducting clinical trials often specify that the usual health care provided to patients who participate in those trials is the control condition. A basic assumption underlying these trials is that all participants in the study, regardless of their study group assignment, continue to receive the usual care provided within the clinical setting. Differences detected in the outcomes at the end of the study are expected to be due to the experimental condition used in the study because that is what is different between the two or more groups (Hulley, Cummings, Browner, Grady, & Newman, 2007) . However, during the study, when there is new evidence, there is the distinct possibility that health care providers may modify usual care. Thus, the assessment and influence of usual care become important considerations when examining the outcomes of a study.
Assessing Usual Care
Modifications in treatment guidelines in the clinical management of patients with HIV/AIDS have advanced because of drug discoveries and the emergence of new evidence regarding their effectiveness and impact on a patient's clinical outcomes (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013) . Such changes in the delivery of usual care have the potential to affect the hypothesized outcomes in an ongoing study when the changes are introduced. All patients who participate in the study receive what is deemed to be usual care. However, these participants may not all receive the same usual care depending on the rate of adoption of the revisions to treatment guidelines at the study site, the level of adherence to the guidelines by the health care providers, and when the participants were recruited into the study. Clearly, usual care is a dynamic condition in which health care providers alter their management of patients based on the latest evidence. Wagner and Kanouse (2003) in their seminal discussion offered three reasons to assess usual care when conducting clinical trials designed to examine the effect of an intervention on adherence to antiretroviral therapy (ART) prescribed for HIV infected patients. First, describing usual care as well as the intervention is necessary for another practice setting to determine whether the tested intervention has the potential to be adopted and effective within a different setting. This is particularly important given the current focus on translating research into practice (Glasziou et al., 2010) . In addition, in a multisite study differences in usual care may provide the explanation for the site differences that occurred in regard to the outcomes. However, this explanation can only be offered when usual care is consistently monitored at each of the participating sites. Finally, health care providers who are also the researchers may begin to change the management of patients in their practice and knowingly or unknowingly provide different care to the participants in the usual care arm. Although, Wagner and Kanouse (2003) focused their comments on ART adherence research, they did not limit the monitoring of usual care to only those trials; they emphasized the need to assess usual care in other studies that include a behavioral intervention.
In 2009, de Bruin, Viechtbauer, Hospers, Schaalma, and Kok called for investigators to report usual care to improve the accuracy of the assessment of change that occurred as a result of a behavioral intervention being tested within a clinical trial. supported this position stating that the components and processes occurring during usual care are important to the overall conduct of the clinical trial. When usual care is based on the latest evidence, it may include components that are also within the behavioral intervention that is being tested in the trial such as health teaching to promote better medication management . The meta-analysis conducted by de Bruin and colleagues (2010) showed that the intervention arm performed better when there was a lower level of usual care provided. As the level of usual care increased and included more of the components in the intervention, there was less effect demonstrated by the intervention being tested .
Yet, investigators do not typically describe the usual care condition within the methods section of a published article raising questions regarding what is actually included in usual care, whether usual care was monitored for any changes in delivery during the study, and how changes in usual care may have affected the hypothesized outcomes (de Bruin et al., 2009) . Without this information the internal validity of the study is threatened (Polit & Beck, 2012) . Descriptions of usual care are even more problematic when a study uses multiple sites because of possible variation in usual care across clinics and differences in practices based on geographic location (Freedland, Mohr, Davidson, & Schwartz, 2011) . Also, whether individuals within a site or sites are randomized within a study needs to be considered.
Despite the need for and value of assessing usual care, only a few methods for monitoring the control condition in a study have been described (Carroll, 1997; Garland, Hurlburt, Brookman-Frazee, Taylor, & Accurso, 2010) . The use of a Theory Coding Scheme designed to capture the components of the theory that are present in the interventions that are delivered in a randomized control trial (RCT) could be extended to the systematic assessment of usual care (Michie, Prestwich, & de Bruin, 2010) . Similarly, the importance of assessing adherence to treatment guidelines cannot be overlooked. Another possible usual care assessment, the Session Report Form developed for a larger clinical trial, has been suggested by Kelley, Vides de Andrade, Sheffer, and Bickman (2010) . The form is completed by health care providers at the end of a usual care session designed for youth being seen for mental health conditions to inform the content addressed and the context in which usual care occurred. Possibly patients could be informants about usual care; however, they may be unable to differentiate the usual care provided to all patients in the clinic setting from the individualized care that they are receiving.
Purpose
Although systematic assessment of usual care has clear advantages in clinical trials with a behavioral intervention, usual care does not necessarily lend itself to rigorous, reliable, or feasible assessment. To our knowledge no standard form for assessing usual care is described in published studies. In addition, there are few reports available to inform how best to monitor usual care. This article describes the assessment of usual care within the 16 studies of the MACH 14 (Multisite Adherence Collaboration in HIV among 14 institutions) collaborative group (Liu et al., 2013) and offers insight into current research practice using those studies as examples when conducting and reporting results from clinical trials.
Method

Design
Data for this descriptive study examining the practice of assessing usual care were provided by the sample of principal investigators within the MACH 14 collaboration and were collected after the studies had ended. MACH 14 includes 16 National Institutes of Health (NIH)-funded studies conducted at 14 different sites in various regions of the United States from 1997 to 2009. Each study focused on medication adherence in patients with HIV/AIDS in which the outcome of adherence in both the usual care/control and intervention arms was assessed using electronic event monitors (Liu et al., 2013) . All studies in MACH 14 received approval from their respective organization's institutional review board.
Sample
Twelve of the 16 studies (75%) in MACH 14 were intervention studies (Liu et al., 2013) . The length of the interventions within these studies varied from 5 to 23 weeks. The experimental condition focused on improving medication adherence and directly or indirectly targeted the participant's behavior. The interventions included one or more of the following components: directly observed therapy, problem solving, counseling, feedback to the participant, peer counseling, and feedback to the physician. Theories and models supporting the interventions incorporated social cognitive theory, contingency management, self-regulation, and motivational interviewing.
Data Collection
MACH 14 investigators initially provided a brief written summary of their intervention and usual care/control study groups. Because these descriptions were rather general, we sought more specific information regarding the assessment of usual care in the 16 studies. We developed a questionnaire for the MACH 14 researchers to complete. If the researchers answered "yes" that they monitored usual care, we asked them to describe how usual care was assessed, when usual care was assessed, the frequency of the assessments, who provided the assessment data, how the data were obtained, and the specific clinical practices within usual care that were assessed. We also invited investigators to provide any additional comments relevant to the assessment of usual care in their particular clinical settings.
Data Analysis
We reviewed each of the general descriptions of usual care provided by the MACH 14 researchers to get a sense of their use of the term usual care. We summarized the data from the questionnaires using descriptive statistics, for example, frequencies and percents.
Results
The initial written descriptions showed that two thirds (n = 10) of the investigators identified usual care as the "procedures provided to all patients." However, when referring to the control condition in their clinical trials, the researchers used diverse terms such as usual care, standard clinic care, standard patient education, or comparison condition. While there was agreement regarding the definition of usual care, there was variability in how the control condition was defined. Usual care was one example of the control condition.
Our findings showed that only one third of the studies in Mach 14 (n = 5) assessed usual care. Responses to how usual care was assessed demonstrated that investigators in four of the studies developed a study-specific form for assessing usual care. However, in the fifth study, the researchers who were also the health care providers in that setting, stated that they were familiar with the usual care practices and therefore did not conduct regular assessments of usual care.
The frequency of the assessments of usual care varied. Four studies assessed usual care at both the beginning and at the end of the study. Two of those four studies also monitored usual care at 3-or 6-month intervals throughout the study. One study assessed usual care only at the beginning; this study was the one where the health care providers were also the researchers. The investigators collected usual care data by telephone, face-to-face interview, electronically, or mail. Most informants providing usual care assessment data were direct care providers within the practice site. For the longitudinal studies that collected usual care data more often, different personnel within the setting provided the information. Thus, there was not continuity across informants.
The clinical practices within usual care that were assessed included HIV medical care (referrals, laboratory monitoring, and physical examinations) and patient education related to HIV infection, HIV medications, and medication adherence. Another practice in the setting that was assessed was a patient's level of medication adherence when that individual was seen for their clinic appointment.
Discussion
Recognizing the importance of the role of usual care in clinical trials, we set out to describe the manner in which usual care was assessed within the 16 studies included in the MACH 14 collaboration as a means of showing the current research practice when conducting clinical trials. The MACH14 sample included both intervention and nonintervention studies from across the United States; these studies spanned nearly 15 years (Liu et al., 2013) . During that time there were new drug discoveries that changed antiretroviral treatment guidelines potentially altering the usual care provided to patients with HIV participating in these longitudinal studies (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013).
The findings available in this report demonstrate that there was limited systematic monitoring of usual care in the trials included in MACH 14. MACH 14 was a convenience sample of studies that assessed adherence to ART using electronic event monitors, as well as other bio-behavioral measures. The assessment of usual care was not a criterion for a study's inclusion in MACH 14. The five studies monitoring usual care were all intervention trials and each had assessments at the beginning of those studies; most assessed usual care at the end of the study. Only a few studies assessed usual care at intervals throughout the course of the study. Researchers in MACH 14 conducting nonintervention studies did not monitor usual care. However, the significance of usual care in observational studies is no less important.
No consistent form for assessing usual care was used across the studies; each study developed its own form. Only particular aspects of usual care within a practice setting may have been included on the assessment form thus limiting the amount of information that was obtained and that could be used to determine the role of usual care on the study outcomes. While these studies attempted to capture any changes in usual care, having more objective measures is preferred and makes tracking changes over time more precise.
Who provided the information about usual care may have affected the information that was collected and made it challenging for the researcher to obtain objective and nonbiased data about current clinic practices. There may have been a "Hawthorne effect" or a social desirability effect when reporting data on usual care practices.
Because participants in some of the studies within MACH 14 were enrolled for 12 months or longer and the interventions lasted between 5 and 23 weeks, there was the distinct possibility that the usual care provided to participants may have differed by the time all participants were enrolled into and completed a particular study. When usual care is monitored only at the start of the study, it is not possible to know if any changes occurred in patient care practices over the length of the investigation or whether the usual care began to include aspects of the experimental condition. If participants are recruited from the community, as well as clinics, it is not possible to gather data on usual care from all the practices where participants received their care. Thus, the usual care received by participants recruited from the community is unknown.
Our limited findings show that usual care assessments occurred intermittently, even those that occurred at multiple time points within a study. With intermittent monitoring, assessments may not be done at the time an evidencedbased practice change was introduced. In addition, summarizing the common elements within usual care when there are multiple health care providers in the practice setting is difficult as all providers may not manage their patients Collect data using an on-site face-to-face interview (preferred approach at least for the initial data collection) Use telephone interview or electronic/mail data collection if unable to use on-site approach Enter data into a database as soon after the data collection as possible Contact the clinic informant to obtain any missing data or to clarify any of the information in the same way. The variability of the available services and what individual patients are offered and receive is difficult to capture within a standardized usual care assessment form. This brief report demonstrates the limited assessment of usual care within both clinical trials and observational studies in MACH 14 supporting findings from earlier meta-analyses, as well as commentaries calling for the need to assess usual care. How the assessment data were used in the analyses within these studies is unknown. Assessing usual care is important to understand the potential impact of changes in clinical practice during the length of a study. A description of the usual care provided to study participants needs to be included when reporting the study findings. Without a clear depiction of usual care, it becomes difficult to make comparisons across studies and conduct systematic reviews or meta-analyses (de Bruin et al., 2009) .
This article suggests that there is a need to develop a protocol within the study to systematically assess usual care throughout the study. Regardless of the research design a process similar to that for monitoring intervention fidelity should be considered (Glasziou et al., 2010; Wickersham et al., 2011) . Monitoring usual care throughout a study and incorporating those data into the analysis will assist researchers to include the influence of usual care on the outcomes of the study and offer changes in usual care as a potential explanation for the findings in the study. Refer to Table 1 for the categories of assessment and recommendations for monitoring usual care.
